[Thermal test of reactive hyperemia: a propos of an objective study of pyridinol carbamate].
The thermal test of reactive hyperhemia (TTHR) gives a global and reliable appreciation of the cutaneous microcirculation, the importance of which is well known. In this study, sixty-one subjects were treated for from one month to one year with pyridinol-carbamate. The TTHR was modified in seventy-nine per cent of the cases, showing a considerable and lasting improvement. The clinical symptoms followed a comparable evolution.
D000328:Adult; D000368:Aged; D001831:Body Temperature; D002199:Capillary Permeability / Q000187:drug effects; D002219:Carbamates / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006940:Hyperemia; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D008875:Middle Aged; D011727:Pyridinolcarbamate / Q000494:pharmacology / Q000627:therapeutic use*; D012867:Skin / Q000098:blood supply*; D014111:Tourniquets; D014652:Vascular Diseases / Q000188:drug therapy*
D002219:Carbamates; D011727:Pyridinolcarbamate
Le test thermique d'hyperhémie réactionnelle. A propos d'une étude objective du phyridinol-carbamate.